天山股份(000877.SZ):預計上半年實現淨利約6.71億元
格隆匯 7 月 13日丨天山股份(000877.SZ)公告,預計上半年實現歸屬於上市公司股東的淨利潤約67,100萬元,比上年同期增長:0.08%。
自2019年1月1日起,公司執行新金融工具會計準則,將原列入可供出售金融資產項目核算的西部建設(證券代碼002302)股票類金融資產按準則分類至以公允價值計量且其變動計入當期損益的金融資產項目進行核算,業績預告期該項資產公允價值變動影響歸屬於上市公司股東的淨利潤約-1,701萬元,較上年同期相比減少業績預告期歸屬於上市公司股東的淨利潤約4,016萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.